Lack of product standard: the export prospect of plant extracts in China is hard to predict

At the press conference of the 13th world pharmaceutical raw materials China Exhibition held recently, China Chamber of Commerce for import and export of pharmaceutical and health products announced that the export volume of plant extracts in the first quarter of this year was US $330 million, an increase of 11.2% year on year However, due to the lack of product standards, the export prospect of plant extracts in China is unpredictable in the future According to the statistics of China Customs, in the first quarter of 2013, the import and export volume of plant extracts in China was US $410 million, up 12.1% year on year Among them, the export volume was US $330 million, an increase of 11.2% year on year, accounting for 47% of the export volume of traditional Chinese medicine Plant extracts continued to maintain a large proportion in the export of traditional Chinese medicine products Yu Zhibin, deputy director of traditional Chinese Medicine Department of China Chamber of Commerce for import and export of medical insurance, pointed out that the export of plant extracts in the first quarter of this year has stepped out of last year's downturn, showing a steady recovery trend, and showing different characteristics in the market and products However, at present, the lack of product standards for plant extracts has been widely criticized by the industry, which has also seriously restricted the healthy development of the industry In 2012, the State Administration of quality supervision, inspection and Quarantine (AQSIQ) adjusted the legal inspection catalogue, and it is still difficult to predict the future of the export of plant extracts that lack standards.